Belldegrun Arie bought URGN
August 26, 2025 · Form 4 insider transaction
Belldegrun Arie bought 20,000 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderBelldegrun Arie
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityStock Option (right ot buy)
Transaction codeA: Grant or award
Transaction dateAugust 26, 2025
Filing dateAugust 27, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.